1. Home
  2. BHST vs LXEO Comparison

BHST vs LXEO Comparison

Compare BHST & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • LXEO
  • Stock Information
  • Founded
  • BHST 2007
  • LXEO 2017
  • Country
  • BHST Canada
  • LXEO United States
  • Employees
  • BHST N/A
  • LXEO N/A
  • Industry
  • BHST
  • LXEO
  • Sector
  • BHST
  • LXEO
  • Exchange
  • BHST Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • BHST 106.0M
  • LXEO 93.9M
  • IPO Year
  • BHST N/A
  • LXEO 2023
  • Fundamental
  • Price
  • BHST $6.69
  • LXEO $2.75
  • Analyst Decision
  • BHST Strong Buy
  • LXEO Strong Buy
  • Analyst Count
  • BHST 2
  • LXEO 6
  • Target Price
  • BHST $13.00
  • LXEO $18.50
  • AVG Volume (30 Days)
  • BHST 11.4K
  • LXEO 984.8K
  • Earning Date
  • BHST 05-15-2025
  • LXEO 05-12-2025
  • Dividend Yield
  • BHST N/A
  • LXEO N/A
  • EPS Growth
  • BHST N/A
  • LXEO N/A
  • EPS
  • BHST N/A
  • LXEO N/A
  • Revenue
  • BHST $27,704,000.00
  • LXEO N/A
  • Revenue This Year
  • BHST $116.40
  • LXEO N/A
  • Revenue Next Year
  • BHST $55.91
  • LXEO N/A
  • P/E Ratio
  • BHST N/A
  • LXEO N/A
  • Revenue Growth
  • BHST 74.76
  • LXEO N/A
  • 52 Week Low
  • BHST $0.00
  • LXEO $1.45
  • 52 Week High
  • BHST $7.38
  • LXEO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • BHST N/A
  • LXEO 45.92
  • Support Level
  • BHST N/A
  • LXEO $2.51
  • Resistance Level
  • BHST N/A
  • LXEO $2.91
  • Average True Range (ATR)
  • BHST 0.00
  • LXEO 0.38
  • MACD
  • BHST 0.00
  • LXEO -0.04
  • Stochastic Oscillator
  • BHST 0.00
  • LXEO 33.62

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: